Search Results 251-260 of 10437 for Cholangitis

  1. Obeticholic Acid (OCA) In Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of obeticholic acid in patients with primary sclerosing cholangitis, evaluating its ...

  2. Science Saturday: Regenerative technology uncovers new discoveries in liver disease - Mayo Clinic News Network

    Primary sclerosing cholangitis attacks the bile duct, causing inflammation and scarring that damages the liver. Bile ducts carry digestive liquid bile from the ...

  3. PERSEUS: Preliminary Efficacy And Safety Of Cenicriviroc In Adult Subjects With Primary Sclerosing Cholangitis - Mayo Clinic

    This is a single-arm, open label, proof of concept (PoC) study of Cenicriviroc (CVC) in adult subjects with Primary Sclerosing Cholangitis (PSC). The main ...

  4. A Study To Evaluate The Effectiveness And Safety Of Obeticholic Acid To Treat Patients With Primary Sclerosing Cholangitis - Mayo Clinic

    A Study To Evaluate The Effectiveness And Safety Of Obeticholic Acid To Treat Patients With Primary Sclerosing Cholangitis ... cholangitis. Participation ...

  5. Biobank for Cholestatic Liver Diseases - Mayo Clinic

    ... cholangitis (PBC) and primary sclerosing cholangitis (PSC). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  6. Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation - Mayo Clinic

    Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation · More about research at ...

  7. Publications - John E. Eaton, M.D. - Mayo Clinic

    ... cholangitis. Hepatology. 2025 Mar 20 [Epub ahead of print] View PubMed; Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ ...

  8. A Long-Term Study Of Elafibranor In Adult Participants With Primary Biliary Cholangitis - Mayo Clinic

    The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive ...

  9. Study Investigating The Activity Of Vidofludimus Calcium As A Treatment For Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    Study Investigating The Activity Of Vidofludimus Calcium As A Treatment For Primary Sclerosing Cholangitis (PSC) ... cholangitis. Participation eligibility.

  10. A Study To Evaluate Efficacy And Safety Of An Investigational Drug Named Volixibat In Patients With Itching Caused By Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    The purpose of this study is to learn more about volixibat for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to ...